Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Alendronic acid.
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Alendronic acid.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alendronic acid.
Advertisement
Aclarubicin
Aclarubicin may increase the hypocalcemic activities of Alendronic acid.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Alendronic acid.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Alendronic acid.
Advertisement
Aluminum
The serum concentration of Alendronic acid can be decreased when it is combined with Aluminium.
Aluminum Hydroxide
The serum concentration of Alendronic acid can be decreased when it is combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The serum concentration of Alendronic acid can be decreased when it is combined with Aluminum hydroxide.
Advertisement
Aluminum Magnesium Silicate
The serum concentration of Alendronic acid can be decreased when it is combined with Almasilate.
Amikacin
Amikacin may increase the hypocalcemic activities of Alendronic acid.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Alendronic acid.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Alendronic acid.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Alendronic acid.
Arbekacin
Arbekacin may increase the hypocalcemic activities of Alendronic acid.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alendronic acid.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Alendronic acid.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Alendronic acid.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Alendronic acid.
Bismuth Subcitrate
The serum concentration of Alendronic acid can be decreased when it is combined with Bismuth Subcitrate.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Alendronic acid.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Alendronic acid.
Calcium Acetate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Acetate.
Calcium Carbonate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Carbonate.
Calcium Chloride
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Chloride.
Calcium Chloride Anhydrous
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Chloride.
Calcium Citrate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Citrate.
Calcium Glubionate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium glubionate.
Calcium gluceptate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Gluceptate.
Calcium Gluconate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium gluconate.
Calcium Lactate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium lactate.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Alendronic acid.
Casein Allergenic Extract
The serum concentration of Alendronic acid can be decreased when it is combined with Casein.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Alendronic acid.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Alendronic acid.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Alendronic acid.
Clofezone
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Rabeprazole.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Alendronic acid.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Alendronic acid.
Daunorubicin
Daunorubicin may increase the hypocalcemic activities of Alendronic acid.
Deferasirox
The risk or severity of adverse effects can be increased when Alendronic acid is combined with Deferasirox.
Dexlansoprazole
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Dexlansoprazole.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Alendronic acid.
Dihydrostreptomycin
Dihydrostreptomycin may increase the hypocalcemic activities of Alendronic acid.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Alendronic acid.
Doxorubicin
Doxorubicin may increase the hypocalcemic activities of Alendronic acid.
Doxorubicin Hydrochloride
Doxorubicin may increase the hypocalcemic activities of Alendronic acid.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Alendronic acid.
Epirubicin
Epirubicin may increase the hypocalcemic activities of Alendronic acid.
Esomeprazole
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Esomeprazole.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Alendronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Alendronic acid.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Alendronic acid.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Alendronic acid.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Alendronic acid.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Alendronic acid.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Alendronic acid.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Alendronic acid.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Alendronic acid.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Alendronic acid.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.
Framycetin
Framycetin may increase the hypocalcemic activities of Alendronic acid.
Gentamicin
Gentamicin may increase the hypocalcemic activities of Alendronic acid.
Hydrotalcite
The serum concentration of Alendronic acid can be decreased when it is combined with Hydrotalcite.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Alendronic acid.
Idarubicin
Idarubicin may increase the hypocalcemic activities of Alendronic acid.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Alendronic acid.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.
Iron Sucrose
The serum concentration of Alendronic acid can be decreased when it is combined with Iron saccharate.
Kanamycin
Kanamycin may increase the hypocalcemic activities of Alendronic acid.
kanamycin A
Kanamycin may increase the hypocalcemic activities of Alendronic acid.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Alendronic acid.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Alendronic acid.
Lansoprazole
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Lansoprazole.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Alendronic acid.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Alendronic acid.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Alendronic acid.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Alendronic acid.
Magnesium Hydroxide
The serum concentration of Alendronic acid can be decreased when it is combined with Magnesium hydroxide.
Magnesium Oxide
The serum concentration of Alendronic acid can be decreased when it is combined with Magnesium oxide.
Magnesium Salicylate
The serum concentration of Alendronic acid can be decreased when it is combined with Magnesium salicylate.
Magnesium Sulfate
The serum concentration of Alendronic acid can be decreased when it is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The serum concentration of Alendronic acid can be decreased when it is combined with Magnesium sulfate.
Magnesium Trisilicate
The serum concentration of Alendronic acid can be decreased when it is combined with Magnesium Trisilicate.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Alendronic acid.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alendronic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alendronic acid.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Alendronic acid.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Alendronic acid.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Alendronic acid.
Metrizamide
Metrizamide may increase the hypocalcemic activities of Alendronic acid.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Alendronic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Alendronic acid.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Alendronic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Alendronic acid.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.
Neomycin
Neomycin may increase the hypocalcemic activities of Alendronic acid.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Alendronic acid.
Netilmicin
Netilmicin may increase the hypocalcemic activities of Alendronic acid.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Alendronic acid.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Alendronic acid.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Alendronic acid.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Alendronic acid.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Alendronic acid.
Omeprazole
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Omeprazole.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Alendronic acid.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Alendronic acid.
Pantoprazole
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Pantoprazole.
Parathyroid Hormone
The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Alendronic acid.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Alendronic acid.
Paromomycin
Paromomycin may increase the hypocalcemic activities of Alendronic acid.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Alendronic acid.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Alendronic acid.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Alendronic acid.
Pirarubicin
Pirarubicin may increase the hypocalcemic activities of Alendronic acid.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Alendronic acid.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.
Plicamycin
Plicamycin may increase the hypocalcemic activities of Alendronic acid.
Rabeprazole
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Rabeprazole.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Alendronic acid.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Alendronic acid.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Alendronic acid.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Alendronic acid.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Alendronic acid.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Alendronic acid.
Sisomicin
Sisomicin may increase the hypocalcemic activities of Alendronic acid.
Spectinomycin
Spectinomycin may increase the hypocalcemic activities of Alendronic acid.
Streptomycin
Streptomycin may increase the hypocalcemic activities of Alendronic acid.
Streptozocin
Streptozocin may increase the hypocalcemic activities of Alendronic acid.
Sucroferric Oxyhydroxide
The serum concentration of Alendronic acid can be decreased when it is combined with Iron saccharate.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Alendronic acid.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Alendronic acid.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Alendronic acid.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Alendronic acid.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Alendronic acid.
Tobramycin
Tobramycin may increase the hypocalcemic activities of Alendronic acid.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Alendronic acid.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Alendronic acid.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Alendronic acid.
Tricalcium Phosphate
The serum concentration of Alendronic acid can be decreased when it is combined with Calcium Phosphate.
Tromethamine
The serum concentration of Alendronic acid can be decreased when it is combined with Tromethamine.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Alendronic acid.
Valrubicin
Valrubicin may increase the hypocalcemic activities of Alendronic acid.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Alendronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Alendronic acid.
